Fresenius SE Revenue 2016-2023 | FSNUY
Fresenius SE annual/quarterly revenue history and growth rate from 2016 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Fresenius SE revenue for the quarter ending September 30, 2023 was $6.006B, a 42.99% decline year-over-year.
- Fresenius SE revenue for the twelve months ending September 30, 2023 was $39.203B, a 9.93% decline year-over-year.
- Fresenius SE annual revenue for 2022 was $43.029B, a 3.07% decline from 2021.
- Fresenius SE annual revenue for 2021 was $44.39B, a 7.12% increase from 2020.
- Fresenius SE annual revenue for 2020 was $41.439B, a 4.49% increase from 2019.
Fresenius SE Annual Revenue
(Millions of US $) |
| 2022 |
$43,029 |
| 2021 |
$44,390 |
| 2020 |
$41,439 |
| 2019 |
$39,658 |
| 2018 |
$39,599 |
| 2017 |
$38,301 |
| 2016 |
$32,183 |
| 2015 |
$30,676 |
Fresenius SE Quarterly Revenue
(Millions of US $) |
| 2023-09-30 |
$6,006 |
| 2023-06-30 |
$11,295 |
| 2023-03-31 |
$10,976 |
| 2022-12-31 |
$10,926 |
| 2022-09-30 |
$10,534 |
| 2022-06-30 |
$10,661 |
| 2022-03-31 |
$10,908 |
| 2021-12-31 |
$11,423 |
| 2021-09-30 |
$10,995 |
| 2021-06-30 |
$11,141 |
| 2021-03-31 |
$10,831 |
| 2020-12-31 |
$11,115 |
| 2020-09-30 |
$10,425 |
| 2020-06-30 |
$9,822 |
| 2020-03-31 |
$10,078 |
| 2019-12-31 |
$10,330 |
| 2019-09-30 |
$9,832 |
| 2019-06-30 |
$9,847 |
| 2019-03-31 |
$9,649 |
| 2018-12-31 |
$10,095 |
| 2018-09-30 |
$9,525 |
| 2018-06-30 |
$9,996 |
| 2018-03-31 |
$9,982 |
| 2017-12-31 |
$10,254 |
| 2017-09-30 |
$9,751 |
| 2017-06-30 |
$9,384 |
| 2017-03-31 |
$8,911 |
| 2016-12-31 |
$8,423 |
| 2016-09-30 |
$8,121 |
| 2016-06-30 |
$8,011 |
| 2016-03-31 |
$7,628 |
| 2015-12-31 |
$7,951 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$16.733B |
$24.011B |
|
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
|
